MARY BRECKINRIDGE HOSPITAL — History
CCN 181316 | 3-year financial timeline | COVID resilience: 65/100
🛡️ Public data only — no PHI permitted on this instance.
$21M
Latest Revenue (FY2022)
+11.2%
Revenue CAGR (3yr)
12.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $17M | $18M | $21M | +16.3% | +11.2% |
| Operating Expenses | $15M | $18M | $19M | +4.3% | +11.4% |
| Operating Margin | 12.5% | 2.2% | 12.3% | +463.8% | -0.9% |
| Net Income | $2M | $0M | $3M | +555.9% | +10.2% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 4,339 | 4,880 | 4,653 | -4.7% | +3.6% |
| Medicare Day % | 42% | 36% | 28% | -21.5% | -17.6% |
| Medicaid Day % | 0% | 1% | 0% | -59.5% | +13.2% |
COVID Impact & Recovery
Resilience Score: 65/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +23.7% ($17M → $21M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.2%
This Hospital
+7.6%
State Avg
Latest Margin
12.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $23M | 12.1% |
| FY2024 (proj) | $25M | 12.0% |
| FY2025 (proj) | $27M | 11.9% |